BIO-TECHNE Corp — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| HIGGINS JOHN L | — | Option Exercise | 4,000 | $22.95 | $91,800 | 40,608 | May 14, 2024 |
| Klimovsky Judith V | — | Award / Grant | 680 | — | — | 680 | May 1, 2024 |
| Bohnen Shane | SVP - General Counsel | Tax Withholding | 747 | $67.87 | $50,699 | 1,647 | Apr 3, 2024 |
| Nusse Roeland | — | Sale | 10,400 | $76.98 | $800,592 | 43,097 | Mar 7, 2024 |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Tax Withholding | 1,111 | $68.54 | $76,148 | 7,759 | Feb 1, 2024 |
| Hippel James | CFO | Option Exercise | 47,289 | $31.26 | $1,478,254 | 104,850 | Dec 19, 2023 |
| Kelderman Kim | Chief Operating Officer | Award / Grant | 14,196 | — | — | 35,421 | Nov 1, 2023 |
| Seth Alpna | — | Award / Grant | 1,625 | — | — | 12,309 | Oct 26, 2023 |
| Bushman Julie L | — | Award / Grant | 1,625 | — | — | 5,673 | Oct 26, 2023 |
| VESSEY RUPERT | — | Award / Grant | 1,625 | — | — | 7,885 | Oct 26, 2023 |
| STEER RANDOLPH C | — | Award / Grant | 1,625 | — | — | 24,201 | Oct 26, 2023 |
| HIGGINS JOHN L | — | Award / Grant | 1,625 | — | — | 36,608 | Oct 26, 2023 |
| KEEGAN JOSEPH D | — | Award / Grant | 1,625 | — | — | 12,309 | Oct 26, 2023 |
| Nusse Roeland | — | Award / Grant | 1,625 | — | — | 53,497 | Oct 26, 2023 |
| BAUMGARTNER ROBERT V | — | Award / Grant | 1,625 | — | — | 43,401 | Oct 26, 2023 |
| Nusse Roeland | — | Sale | 8,939 | $80.32 | $717,980 | 51,872 | Aug 30, 2023 |
| Kelderman Kim | Pres. Diagnostics & Genom | Option Exercise | 2,100 | $47.60 | $99,960 | 21,225 | Aug 24, 2023 |
| Kummeth Charles R. | Chief Executive Officer | Option Exercise | 17,632 | — | — | 1,286,944 | Aug 15, 2023 |
| Kummeth Charles R. | Chief Executive Officer | Gift | 9,008 | — | — | 1,269,312 | Aug 9, 2023 |
| Kummeth Charles R. | Chief Executive Officer | Tax Withholding | 31,962 | $82.17 | $2,626,318 | 1,278,320 | Aug 5, 2023 |
| Hippel James | CFO | Option Exercise | 12,876 | — | — | 63,896 | Aug 5, 2023 |
| Kelderman Kim | Pres. Diagnostics & Genom | Tax Withholding | 4,139 | $82.17 | $340,102 | 19,125 | Aug 5, 2023 |
| Kummeth Charles R. | Chief Executive Officer | Sale | 80,000 | $88.36 | $7,068,800 | 1,258,766 | Jul 21, 2023 |
| Kummeth Charles R. | Chief Executive Officer | Tax Withholding | 390,727 | $81.63 | $31,895,045 | 1,338,766 | Jun 30, 2023 |
| Kummeth Charles R. | Chief Executive Officer | Sale | 322 | $83.00 | $26,726 | 1,112,817 | Jun 7, 2023 |
| HIGGINS JOHN L | — | Tax Withholding | 4,377 | $79.88 | $349,635 | 34,983 | Apr 28, 2023 |
| Nusse Roeland | — | Gift | 377 | — | — | 28,811 | Apr 19, 2023 |
| Kummeth Charles R. | Chief Executive Officer | Tax Withholding | 255,837 | $84.39 | $21,590,084 | 1,113,139 | Jan 4, 2023 |
| Furlow Brenda S. | SVP - GENERAL COUNSEL | Sale | 800 | $82.01 | $65,608 | 26,092 | Dec 8, 2022 |
| HIGGINS JOHN L | — | Award / Grant | 338 | — | — | 5,840 | Oct 27, 2022 |
| BAUMGARTNER ROBERT V | — | Award / Grant | 338 | — | — | 10,444 | Oct 27, 2022 |
| VESSEY RUPERT | — | Award / Grant | 338 | — | — | 1,565 | Oct 27, 2022 |
| Nusse Roeland | — | Award / Grant | 338 | — | — | 7,297 | Oct 27, 2022 |
| KEEGAN JOSEPH D | — | Award / Grant | 338 | — | — | 2,671 | Oct 27, 2022 |
| Bushman Julie L | — | Award / Grant | 338 | — | — | 1,012 | Oct 27, 2022 |
| Seth Alpna | — | Award / Grant | 338 | — | — | 2,671 | Oct 27, 2022 |
| STEER RANDOLPH C | — | Award / Grant | 338 | — | — | 5,644 | Oct 27, 2022 |
| Kelderman Kim | Pres. Diagnostics & Genom | Option Exercise | 663 | $150.78 | $99,967 | 3,801 | Aug 23, 2022 |
| HIGGINS JOHN L | — | Sale | 900 | $373.99 | $336,591 | 7,106 | Aug 10, 2022 |
| Furlow Brenda S. | SVP - General Counsel | Option Exercise | 563 | $177.32 | $99,831 | 6,523 | Aug 8, 2022 |
| Kelderman Kim | Pres. Diagnostics & Genom | Tax Withholding | 1,214 | $382.97 | $464,926 | 3,138 | Aug 7, 2022 |
| Kummeth Charles R. | Chief Executive Officer | Tax Withholding | 11,557 | $382.97 | $4,425,984 | 240,403 | Aug 7, 2022 |
| Hippel James | Chief Financial Officer | Tax Withholding | 1,938 | $382.97 | $742,196 | 12,755 | Aug 7, 2022 |
| Kummeth Charles R. | CHIEF EXECUTIVE OFFICER | Option Exercise | 45,346 | $108.49 | $4,919,588 | 262,749 | Jul 28, 2022 |
| Kummeth Charles R. | CHIEF EXECUTIVE OFFICER | Tax Withholding | 30,935 | $362.78 | $11,222,599 | 217,403 | Jul 6, 2022 |
| HIGGINS JOHN L | — | Option Exercise | 600 | $66.90 | $40,140 | 5,206 | Jun 8, 2022 |
| Kummeth Charles R. | CHIEF EXECUTIVE OFFICER | Sale | 5,104 | $365.00 | $1,862,960 | 198,338 | Jun 7, 2022 |
| BAUMGARTNER ROBERT V | — | Purchase | 300 | $352.55 | $105,765 | 10,106 | May 10, 2022 |
| Kelderman Kim | Pres. Diagnostics & Genom | Option Exercise | 1,989 | $150.78 | $299,901 | 1,989 | Feb 8, 2022 |
| Geist William | President, Protein Sciences | Award / Grant | 2,490 | — | — | 2,490 | Feb 1, 2022 |